NAD+ explained without the longevity hype
By Alfred Belvedere — Founder, Omni AI
“The marketing for nAD+ explained without the longevity hype is a different product than the practice for it. The practice is where the value sits.”
NAD+ explained without the longevity hype sits at a crossroads of practice and marketing. The marketing side is loud; the practice side is quieter and more useful. Careful, what evidence actually supports.
Today’s Key Insights
Mechanism first: On the Prime IV Hydration side, the practical version of this is shaped by IV vitamin drips. The marketing tends to talk about results and skip the chemistry; we'd rather front-load the chemistry and let the results explain themselves.
Dose, timing, and pairing are the three knobs that actually move outcomes. The Prime IV Hydration bench has seen this pattern enough that we calibrate against it before we adjust the menu. A frequent error is to treat them as fixed and adjust the menu instead — the right move is the opposite.
Operationally, here's what we'd do if we were you: For Prime IV Hydration clients specifically, we'd start at the smallest viable version and let the numbers earn the next step. Don't optimize for novelty. Optimize for the smallest change that fits your existing pattern and run it for at least four cycles.
Power Move
Ask the practitioner the question you've been polite about. nAD+ explained without the longevity hype is one of those areas where the obvious question is the right question.
NAD+ explained without the longevity hype
That’s the signal — here’s the move. Book a free 30-minute strategy session and we’ll walk through exactly how to apply today’s insight to your revenue, your team, and your next 90 days. No pitch. Just straight advice from operators who run AI systems for a living.
New here? Reply to the dispatch with your timezone and we'll send you our preferred-slot calendar before it fills.
30 minutes · free · no obligation
Powered by Omni AI
More from Interlinked
Migraine relief without the abortive crash
Migraine relief without the abortive crash sits at a crossroads of practice and marketing. The marketing side is loud; the practice side is …
IV therapy myth: “it’s only for celebrities”
We get asked about iV therapy myth: “it’s only for celebrities” more than almost any other question on the menu. Myth-busting. The honest an…
Why we do NAD+ over hours, not minutes
We get asked about why we do NAD+ over hours, not minutes more than almost any other question on the menu. Protocol explanation. The honest …
Today's trending · Omni AI
Big Companies Are Firing Teams to Fund AI. Is Yours Ready?
Atlassian lays off 10% of workforce to redirect resources toward AI
See the trending brief →